A new publication referencing sincalide appeared on September 9, 2026. The paper, titled "MEX3A mediates DHRS3 instability to relieve G0/G1 arrest and facilitate hepatocellular carcinoma tumorigenesis and progression," was published in Biochemical Pharmacology.
The publication is indexed under PubMed ID 42716134. This brief reports only the existence and title of the publication as listed in the source record. No findings, conclusions, or data from the study are summarized here.
Sincalide remains an approved compound. This item reflects a new entry in the scientific literature associated with it, not a regulatory action or safety event.
Readers interested in the broader context of sincalide, including its approved uses and regulatory background, can consult the compound overview for additional information.